|
 |
|
|||||||
|
|||||||||
Papers In Press, published online ahead of print December 1, 2003
J. Lipid Res., doi:10.1194/jlr.R300016-JLR200
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biochemistry Dept., University of Missouri, Columbia, MO 65211
Corresponding Author: sung{at}health.missouri.edu
Phospholipases A2 (PLA2) belong to a family of enzymes catalyzing the cleavage of fatty acids from the sn-2 position of phospholipids. There are 19+ different isoforms of PLA2 in the mammalian system, but recent studies have focused on three major groups: namely, the group IV cytosolic PLA2 (cPLA2), the group II secretory PLA2 (sPLA2) and the group VI Ca2+-independent PLA2 (iPLA2). These PLA2 are involved in a complex network of signaling pathways linking receptor agonists, oxidative agents and pro-inflammatory cytokines to the release of arachidonic acid (AA) and the synthesis of eicosanoids. PLA2 acting on membrane phospholipids have been implicated in intracellular membrane trafficking, differentiation, proliferation, and apoptotic processes. All major groups of PLA2 are present in the Central Nervous System (CNS). Therefore, this review is focused on PLA2 and AA release in neural cells, especially in astrocytes and neurons. In addition, because many neurodegenerative diseases are associated with increased oxidative and inflammatory responses, an attempt was made to include studies on PLA2 in cerebral ischemia, Alzheimer's disease and neuronal injury due to excitotoxic agents. Information from these studies has provided clear evidence for the important role of PLA2 in regulating physiological and pathological functions in the CNS.
Revised on November 26, 2003
Accepted on November 26, 2003
Phospholipase A2 in the central nervous system: Implications for neurodegenerative diseases
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  D. J. Mancuso, P. Kotzbauer, D. F. Wozniak, H. F. Sims, C. M. Jenkins, S. Guan, X. Han, K. Yang, G. Sun, I. Malik, et al. Genetic Ablation of Calcium-independent Phospholipase A2{gamma} Leads to Alterations in Hippocampal Cardiolipin Content and Molecular Species Distribution, Mitochondrial Degeneration, Autophagy, and Cognitive Dysfunction J. Biol. Chem., December 18, 2009; 284(51): 35632 - 35644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Bazan Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease J. Lipid Res., April 1, 2009; 50(Supplement): S400 - S405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Lukiw and N. G. Bazan Docosahexaenoic Acid and the Aging Brain J. Nutr., December 1, 2008; 138(12): 2510 - 2514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Bazan Homeostatic Regulation of Photoreceptor Cell Integrity: Significance of the Potent Mediator Neuroprotectin D1 Biosynthesized from Docosahexaenoic Acid The Proctor Lecture Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 4866 - 4881. [Full Text] [PDF]
|
|
|
|
|
|
T. Takajo, K. Tsuchida, T. Murahashi, K. Ueno, and I. Koshiishi Intramolecular rearrangement of linolenate peroxyl radicals in lipoxygenase reactions at lower oxygen content J. Lipid Res., April 1, 2007; 48(4): 855 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Zhu, Y. Lai, P. B. Shelat, C. Hu, G. Y. Sun, and J. C-M. Lee Phospholipases A2 Mediate Amyloid-beta Peptide-Induced Mitochondrial Dysfunction J. Neurosci., October 25, 2006; 26(43): 11111 - 11119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Farooqui, W.-Y. Ong, and L. A. Horrocks Inhibitors of Brain Phospholipase A2 Activity: Their Neuropharmacological Effects and Therapeutic Importance for the Treatment of Neurologic Disorders Pharmacol. Rev., September 1, 2006; 58(3): 591 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Farooqui and L. A. Horrocks Phospholipase A2-Generated Lipid Mediators in the Brain: The Good, the Bad, and the Ugly Neuroscientist, June 1, 2006; 12(3): 245 - 260. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Alloisio, R. Aiello, S. Ferroni, and M. Nobile Potentiation of Native and Recombinant P2X7-Mediated Calcium Signaling by Arachidonic Acid in Cultured Cortical Astrocytes and Human Embryonic Kidney 293 Cells Mol. Pharmacol., June 1, 2006; 69(6): 1975 - 1983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sang, J. Zhang, V. Marcheselli, N. G. Bazan, and C. Chen Postsynaptically Synthesized Prostaglandin E2 (PGE2) Modulates Hippocampal Synaptic Transmission via a Presynaptic PGE2 EP2 Receptor J. Neurosci., October 26, 2005; 25(43): 9858 - 9870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Perez, R. Melero, M. A. Balboa, and J. Balsinde Role of Group VIA Calcium-independent Phospholipase A2 in Arachidonic Acid Release, Phospholipid Fatty Acid Incorporation, and Apoptosis in U937 Cells Responding to Hydrogen Peroxide J. Biol. Chem., September 24, 2004; 279(39): 40385 - 40391. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |